Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Nicotinamide Riboside in Mitochondrial Biogenesis

NCT03432871 is registered in ClinicalTrials.gov with Cambridge University Hospitals NHS Foundation Trust as lead sponsor.

NCT NCT03432871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03432871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Nicotinamide Riboside in Mitochondrial Biogenesis
Lead sponsor
Cambridge University Hospitals NHS Foundation Trust
Phase
Not applicable
Overall status
Completed
Start date
December 8, 2017
Completion date
December 31, 2022
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melas, mitochondria dna deletion, mitochondrial diseases, mitochondrial myopathies, progressive external ophthalmoplegia, progressive ophthalmoplegia, progressive; ophthalmoplegia, external